FDA Approved: GABAPENTIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for gabapentin submitted by Zydus Pharmaceuticals USA Inc. under ANDA 078926.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Neuropathic Pain
• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)